These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 947739)

  • 21. Mucosal changes in gastric ulceration and their response to carbenoxolone sodium.
    Steer HW; Colin-Jones DG
    Gut; 1975 Aug; 16(8):590-7. PubMed ID: 810394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of carbenoxolone Na on acute and chronic gastric ulcer models in experimental animals.
    Okabe S; Takata Y; Takeuchi K; Naganuma T; Takagi K
    Am J Dig Dis; 1976 Aug; 21(8):618-25. PubMed ID: 986116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of chronic peptic ulcer and its complications.
    Piper DW; Cumberland VH; Fevre DI
    Drugs; 1975; 10(1):56-66. PubMed ID: 1164901
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of peptic ulcer with Biogastrone (carbenoxolone)].
    Brailski Kh; Dimitrov B
    Vutr Boles; 1979; 18(5):37-44. PubMed ID: 516651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Undesirable effects of carbenoxolone treatment in patients with ulcus ventriculi].
    Henrichsen L; Pedersen H; Jensen KB; Wulff HR
    Ugeskr Laeger; 1976 Dec; 138(51):3265-7. PubMed ID: 793123
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of carbenoxolone sodium on the plasma 11 hydroxycorticoid levels in chronic gastric ulceration.
    Gollan JL; Hecker R; Mackinnon AM
    Aust N Z J Med; 1975 Jun; 5(3):231-4. PubMed ID: 1057935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Duodenal ulcer treated by carbenoxolone sodium. Endoscopically controlled trial (author's transl)].
    Carrilho FJ; Onishi I; Soares EC; Zeitune JM; Pareja JC; Amorim Filho J
    Arq Gastroenterol; 1978; 15(4):167-74. PubMed ID: 749854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Carbenoxolone in the treatment of duodenal ulcer].
    Kadish U; Neeman A
    Harefuah; 1979 Sep; 97(5-6):111-2. PubMed ID: 540839
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum carbenoxolone in patients with gastric and duodenal ulcer: Absorption, efficacy and side-effects.
    Baron JH; Gribble JN; Rhodes C; Wright PA
    Gut; 1978 Apr; 19(4):330-5. PubMed ID: 648939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical treatment of gastric and duodenal ulcer.
    Baron JH
    Klin Wochenschr; 1976 Oct; 54(19):915-25. PubMed ID: 790009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The assessment and management of peptic ulcer.
    Gibbs D
    Br J Hosp Med; 1981 Mar; 25(3):278, 280, 282-3. PubMed ID: 6111368
    [No Abstract]   [Full Text] [Related]  

  • 32. Electrolyte status in duogastrone--treated duodenal ulcer patients.
    Odutola TA; Oladapo JM; Falaiye JM
    Niger Med J; 1978 Jul; 8(4):337-9. PubMed ID: 726667
    [No Abstract]   [Full Text] [Related]  

  • 33. Gastric ulcer under modern medical management.
    Montgomery RD
    J R Coll Physicians Lond; 1977 Jan; 11(2):181-94. PubMed ID: 320328
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of carbenoxolone sodium on human gastric acid secretion.
    Baron JH
    Gut; 1977 Sep; 18(9):721-2. PubMed ID: 604192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective drugs in the treatment of gastroduodenal ulcer disease.
    Koelz HR
    Scand J Gastroenterol Suppl; 1986; 125():156-64. PubMed ID: 3547612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric epithelial cell turnover, mucus production, and healing of gastric ulcers with carbenoxolone.
    Domschke W; Domschke S; Hagel J; Demling L; Croft DN
    Gut; 1977 Oct; 18(10):817-20. PubMed ID: 590840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of pirenzepine and carbenoxolone in the treatment of chronic gastric ulcer. A double-blind endoscopic trial.
    Bianchi Porro G; Petrillo M; Lazzaroni M; Mazzacca G; Sabbatini F; Piai G; Dobrilla G; De Pretis G; Daniotti S
    Hepatogastroenterology; 1985 Dec; 32(6):293-5. PubMed ID: 3912314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the combinations atropine + cyproheptadine and atropine + carbenoxolone in duodenal ulcer therapy.
    Tárnok F; Deák G; Jávor T; Mózsik G; Nagy L; Patty I
    Int J Tissue React; 1983; 5(3):315-21. PubMed ID: 6654627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New perspectives in the treatment of peptic ulcer and related conditions.
    Milton-Thompson GJ; Misiewicz JJ
    Trans Med Soc Lond; 1977-1978; 94():46-57. PubMed ID: 317762
    [No Abstract]   [Full Text] [Related]  

  • 40. Drugs in the treatment of gastric and duodenal ulcer.
    Langman MJ
    Drugs; 1977 Aug; 14(2):105-15. PubMed ID: 19225
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.